Latest Posts

- 11TH DECEMBER 2025
- 0
MHRA Class 2 Medicines Recall: Clarithromycin 500 mg powder for concentrate for solution for infusion (Hameln Pharma Ltd)
MHRA Class 2 Medicines Recall: Clarithromycin 500 mg powder for concentrate for solution for infusion (Hameln Pharma Ltd) Drug alert number: EL(25)A/53 Date issued: 11 December 2025 Hameln Pharma Ltd is recalling certain batches of Clarithromycin 500 mg powder for concentrate for solution for infusion. DMRC reference number: DMRC-37790612 Company name: Hameln Pharma ltd Medicine Details
- Community Pharmacy England News
- 10TH DECEMBER 2025
- 0
Curbing patient abuse
Pharmacy owners and their teams work hard to support local communities every day, but more than half of pharmacy staff reported that abuse from patients is a serious concern in the 2025 Pharmacy Pressures Survey. If you face any type of abuse from patients, please don’t feel like you have to tolerate it. The following
- Community Pharmacy England News
- 10TH DECEMBER 2025
- 0
Improved price concession for Propranolol 40mg tablets for November 2025
Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined the November 2025 concessionary price for Propranolol 40mg tablets: Drug Pack size Price concession Propranolol 40mg tablets 28 £2.28 (previously £1.61) The improved price will apply to prescriptions submitted for payment for
- Community Pharmacy England News
- 10TH DECEMBER 2025
- 0
Class 4 Medicines Defect Notification: Amitriptyline hydrochloride 10mg, 25mg, 50mg tablets (Flamingo Pharma UK Ltd)
MHRA Class 4 Medicines Defect Notification: Amitriptyline hydrochloride 10mg, 25mg, 50mg tablets (Flamingo Pharma UK Ltd) Drug alert number: EL(25)A/52 Date issued: 10 December 2025 Flamingo Pharma UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the products listed in this notification do not contain all the required safety information. DMRC reference
- Community Pharmacy England News
- 9TH DECEMBER 2025
- 0
Joint Primary Care Statement on the Budget 2025
Following on from the Budget announcement at the end of November, Community Pharmacy England has joined forces with other national primary care bodies to reiterate our call on Government to commit to “clear and decisive action” to support primary care. The joint statement, copied below, has been signed by Community Pharmacy England, the British Dental
- Community Pharmacy England News

- 9TH DECEMBER 2025
- 0
Medicine Supply Notification: Nifedipine (Fortipine® LA) 40mg modified-release tablets
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Nifedipine (Fortipine® LA) 40mg modified-release tablets. MSN/2025/064 Tier 2 – medium impact Date o/064f issue: 8th December 2025 Nifedipine (Fortipine® LA) 40mg modified-release tablets are currently out of stock. The resupply date is yet to be confirmed. Other brands of nifedipine
- Community Pharmacy England News
- 8TH DECEMBER 2025
- 0
Media training offer: Become an ambassador for community pharmacy
Training on giving media interviews and handling the press is being offered to pharmacy owners, team members and LPCs. Raising awareness of the work community pharmacies do and the challenges they face is an essential part of Community Pharmacy England’s work and something that the whole sector can get behind and support. We know that
- Community Pharmacy England News
- 5TH DECEMBER 2025
- 0
LPC Conference plans pharmacy’s path in NHS transformation
Local pharmacy leaders from across the country met to discuss critical issues and consider ways to secure community pharmacy’s place in plans to develop the health service. The Annual Conference of LPC Representatives held last week considered important topics for the coming year with speakers sharing insights on the 10 Year Health Plan, healthcare networks,
- Community Pharmacy England News
- 4TH DECEMBER 2025
- 0
Rolled over price concessions for December 2025
The following price concessions granted in November 2025 have rolled over to December 2025: Drug Pack size November 2025 price concession Carbocisteine 375mg capsules 120 £2.95 Pyridostigmine bromide 60mg tablets 200 £15.79 Repaglinide 1mg tablets 90 £31.73 Please note any rolled over prices can be adjusted upwards if we receive reports from pharmacy owners to
- Community Pharmacy England News
- 3RD DECEMBER 2025
- 0
November 2025 Price Concessions – Final Update
The Department of Health and Social Care (DHSC) has today (03/12/2025) confirmed the following final list of price concessions for November 2025. Drug Pack size Price concession Amiodarone 200mg tablets 28 £5.99 Aripiprazole 2.5mg tablets 28 £31.14 Carbocisteine 375mg capsules 120 £2.95 Estriol 0.01% vaginal cream with applicator 1 £47.05 Pyridostigmine bromide 60mg tablets 200 £15.79 Repaglinide
- Community Pharmacy England News

Latest News